Norden Group LLC Takes Position in National Research Co. (NASDAQ:NRC)

Norden Group LLC acquired a new stake in National Research Co. (NASDAQ:NRC) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,324 shares of the company’s stock, valued at approximately $182,000.

Several other hedge funds also recently bought and sold shares of NRC. Algert Global LLC boosted its position in shares of National Research by 94.0% during the 3rd quarter. Algert Global LLC now owns 82,921 shares of the company’s stock valued at $1,896,000 after acquiring an additional 40,182 shares during the last quarter. Barclays PLC grew its stake in National Research by 65.6% in the 3rd quarter. Barclays PLC now owns 51,331 shares of the company’s stock worth $1,175,000 after buying an additional 20,331 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of National Research by 8.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company’s stock worth $393,000 after buying an additional 1,373 shares during the last quarter. FMR LLC increased its holdings in shares of National Research by 397.3% in the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after buying an additional 2,352 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of National Research by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company’s stock valued at $9,619,000 after buying an additional 13,039 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Up 0.9 %

Shares of NASDAQ:NRC opened at $14.23 on Thursday. The firm has a fifty day moving average of $16.90 and a 200 day moving average of $18.92. National Research Co. has a 52-week low of $13.74 and a 52-week high of $40.77. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The firm has a market capitalization of $334.06 million, a PE ratio of 13.55 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Monday, January 27th. The company reported $0.28 earnings per share for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.